Exchange: NASDAQ·Updated 05:02 PM EDT
BGLC logo

BGLCBioNexus Gene Lab Corp

$2.45
$0.19
(7.28%)
Today
Closed $2.42
$0.0278
(1.15%)
After Hours
Mkt Cap$6.31M
Vol13,949.00
News
all
press releases
News Placeholder
BGLC Stock Tumbled Over 13% Today: Why Is VitaGuard Commercialization Agreement Drawing Investor Attention?
The partnership aims to support the planned commercialization of minimal residual disease testing in Southeast Asia.
Stocktwits
<
...
1
>

Advertisement|Remove ads.